University Of Keele
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1949-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.keele.ac.uk
Clinical Trials
44
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (33 trials with phase data)• Click on a phase to view related trials
Can Wearable Technology be Used to Predict Exercise Intensity
- Conditions
- Myocardial Infarction (MI)
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Keele University
- Target Recruit Count
- 24
- Registration Number
- NCT06871943
Developing Allogeneic Musculoskeletal Therapies
- Conditions
- Osteoarthritis
- First Posted Date
- 2023-12-13
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Keele University
- Target Recruit Count
- 325
- Registration Number
- NCT06167928
- Locations
- 🇬🇧
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust, Oswestry, Shropshrie, United Kingdom
Which Automated Methodology?
- Conditions
- Recruitment
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Keele University
- Target Recruit Count
- 8880
- Registration Number
- NCT06049056
- Locations
- 🇬🇧
NIHR CRN: West Midlands, Wolverhampton, United Kingdom
The National Musculoskeletal Audit and Research Database
- Conditions
- Musculoskeletal Diseases
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Keele University
- Target Recruit Count
- 22000
- Registration Number
- NCT05842915
- Locations
- 🇬🇧
Keele University, Keele, Staffordshire, United Kingdom
Symptom Patterns and Life With Longer Term COVID-19 in Children and Young People (SPLaT-19 Cohort & Qualitative Study)
- Conditions
- Pediatric ALLCOVID-19
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Keele University
- Target Recruit Count
- 502
- Registration Number
- NCT05422937
- Locations
- 🇬🇧
Keele University, Newcastle Under Lyme, Staffordshire, United Kingdom
- Prev
- 1
- 2
- 3
- Next
News
10-Year Data Confirms 1-Week Radiotherapy as Effective as 3-Week Course for Early-Stage Breast Cancer
Phase III FAST-Forward trial demonstrates that a 1-week radiotherapy course (26-27 Gy in 5 treatments) provides equivalent cancer control to the standard 3-week regimen (40 Gy in 15 treatments) after 10 years of follow-up.
Young Smokers Face Double the Risk of Unexplained Strokes, Study Reveals
New research shows smoking more than doubles the risk of cryptogenic strokes in adults under 50, with heavy smokers facing over four times the risk compared to non-smokers.